Interní Med. 2009; 11(7): 324-326

Prevention of contrast-induced nephropathy in patients with chronic renal insufficiency

MUDr. Jana Reiterová Ph.D
Klinika nefrologie 1. LF UK a VFN, Praha

Renal toxicity of iodinated radiocontrast media is a major cause of acute renal failure in hospitalised patients. The incidence of contrast-

induced nephropathy in patients with chronic renal insufficiency is about 30 %. The most optimal preventive strategy is adequate

hydration, rational indication of invasive procedures and the use of iso-osmolar, non-ionic contrast-media. N-acetylcystein is often

discussed as a preventive drug in recent years. It was found recently, that gadolinium-enhanced magnetic resonance can lead to acute

renal failure in patients with chronic renal insufficiency. Moreover, gadolinium is associated with a severe, life-threatening nephrogenic

systemic fibrosis in patients with renal insufficiency.

Keywords: contrast media, nephropathy, hydratation, acetylcystein, bicarbonate.

Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Reiterová J. Prevention of contrast-induced nephropathy in patients with chronic renal insufficiency. Interní Med. 2009;11(7):324-326.
Download citation

References

  1. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379-386. Go to original source... Go to PubMed...
  2. McCullough PA, Wolyn R, Rocher L, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortalitz. Am J Med 1997; 103: 368-375. Go to original source... Go to PubMed...
  3. Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 93: 29-34. Go to original source... Go to PubMed...
  4. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prezent acute decreases in renal function induced by radiocontrast agents. N Engl J med 1994; 331: 1416-1420. Go to original source... Go to PubMed...
  5. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with podium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328-2334. Go to original source... Go to PubMed...
  6. Dam M, Wetzels J. Toxicity of contrast media: an update. Ether J Med 2008; 66: 416-421.
  7. From AM, Bartholmai BJ, Williams AW, et al. Podium bicarbonate is associated with an increased incidence of contrast nephropathy. Clin J Am Soc Nephrol 2008; 3: 10-18. Go to original source... Go to PubMed...
  8. Briguori C, Airoldi F, D´Andrea D. Renal insufficiency following contrast media administration trial. A randomized comparison of 3 preventive strategie. Circulation 2007; 115: 1211-1217. Go to original source... Go to PubMed...
  9. Navaneethan SD, Singh S, Appasamy S, et al. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 617-627. Go to original source... Go to PubMed...
  10. Morikawa S, Sone T, Tsuoboi H, et al. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. J Am Coll Cardiol 2009; 53: 1040-1046. Go to original source... Go to PubMed...
  11. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographiccontrast-agent-induced reductions in renal function by acetylcystein. N Engl J Med 2000; 343: 180-184. Go to original source... Go to PubMed...
  12. Kelly AM, Dwarmena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nepropathy. Ann Intern Med 2008; 148: 284-294. Go to original source... Go to PubMed...
  13. Ergun I, Keven K, Uruc I, et al. The safety of gadolinium in patients with stage 3 and $ renal failure. Nephrol Dial Transplant 2006; 21: 697-700. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.